Is LENZ Therapeutics, Inc. (LENZ) a Buy, Sell, or Hold?
LENZ Therapeutics, Inc.
NASDAQ:LENZ
$4.85 USD
-$0.08 (-1.62%)
- Volume
- 577.64K
- Average Volume
- 836.63K
- Market Capitalization
- $152.07M
- P/E Ratio
- -1.35
- Dividend Yield
- 0.00%
- Price Target
- $12.00
- Year High
- $50.40
- Year Low
- $4.78
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $10.40
Analyst Rating
Sell
2 Rating Score
UPSIDE/DOWNSIDE
-59.6% DOWNSIDE
$12.00 Price Target
UPSIDE/DOWNSIDE HIGH
-59.6% DOWNSIDE
$12.00 Price Target High
UPSIDE/DOWNSIDE LOW
-59.6% DOWNSIDE
$12.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Matthew Caufield | $56 | $30.87 | 2025-10-27 06:52 AM | 81.4% |
| Piper Sandler | Biren Amin | $51 | $23.24 | 2025-04-14 06:36 AM | 119.4% |
| Piper Sandler | Joseph Catanzaro | $36 | $22.25 | 2024-08-15 04:44 AM | 61.8% |
| Citigroup | Yigal Nochomovitz | $32 | $23.5 | 2024-08-15 12:58 AM | 36.2% |